AIFA National Report 2019 'The use of antibiotics in Italy'

On 29 December, the 2019 National Report 'The use of antibiotics in Italy' was presented, which provides data and analysis on consumption and expenditure trends in Italy for antibiotics for human use.

You can read it here: https://www.aifa.gov.it/l-uso-degli-antibiotici-in-italia%C2%A0

Our highlights:

In 2019, antibiotic consumption in Italy is unchanged compared to 2018 (21.4 DDD/1000 inh. die) and remains above the European average
There is considerable variability in regional use with higher values in the South than in Central and Northern Italy. The differences concern the number of prescriptions and the type of antibiotics prescribed
Regional variability and wide seasonal fluctuations in consumption suggest a use that is not always appropriate
Fluoroquinolone consumption is reduced but areas of inappropriateness remain
2016-2019: consumption in contracted care (provided by public and private pharmacies) reduced by 5.8%, below the target set by the National Antibiotic Resistance Plan (PNCAR) for 2020 (reduction >10%)
2016-2019: hospital consumption increased, despite the slight reduction observed in the last year, while the PNCAR target was a reduction >5%

AIFA meets

On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency

Special Commission Update No. 3 - Towards the reform of the governance of the Italian Medicines Agency and the Single Commission: where are we?

Update 20 November 2023 The extraordinary State-Regions Conference held on 16 November 2023 sanctioned the long-awaited agreement on the Minister of Health's draft regulation,

Towards the reform of governance of the Italian Medicines Agency and the Single Committee

This is our English version of the analysis 'Towards the reform of governance of the Italian Medicines Agency and the Single Committee' produced in collaboration